Epigenetics: A Global Strategic Business Report
San Jose, California (PRWEB) February 16, 2010
Epigenetics represents a rapidly growing filed in the biological sciences industry, with manifold research articles being circulated all over the world. Biological researchers are increasingly attempting to discover the process of cells exploiting the information programmed in the genome. Epigenetics is the study of the regulation of mechanisms other than DNA sequence over the genomic information programmed in the DNA sequence. All those non-DNA sequence components are highly influential on gene expressions by switching genes off and on. The means of epigenetics are integral to general development and linked with disorders and diseases. Recent findings in this area are expected to bring about major applications in the healthcare and treatment of diseases in the long term.
Although cancer has been regarded a mutational disease for a long time, it has remained a key area for epigenetic diagnostics and therapeutics. Most of the attention in the epigenetic research and development is devoted to DNA methylation, the histone changes as biomarkers have recently drawn attention. Advances in technology and science are driving this surge. Researchers are obtaining a firm base in gaining knowledge about histone changes that affect health and disorders. This knowledge is a key ingredient of the supposed histone code theory. New revelations in throughput genomic epigenetic recognition methods that are enabled by the new deep sequencing technologies appear to the useful in histone decoding. Following the finding of its epigenetic effect, physicians studied its application in other fields.
Stem cells also represent an enthusiastic area in epigenetics. The study of epigenetic alterations that regulate the cell development enables researchers to determine the type of tissue a stem cell turns into. Epigenetic features possibly play a major role in temporary adaptation of species through the use of reversible phenotype variability. The changes which take place in epigenetic features linked with a particular region of DNA permit organisms, measuring over a multigenerational time scale, to swap among phenotypes which express and repress that particular gene.
Key players profiled in the report include Celgene Corporation, CellCentric Ltd., Epigenomics AG, Epigentek Group Inc., Genpathway Inc., Merck & Co. Inc., MGI Pharma Inc., Millipore Corporation, OncoMethylome Sciences S.A., and Orion Genomics.
The report titled "Epigenetics: A Global Strategic Business Report" announced by Global Industry Analysts, Inc., provides market overview, product overview, product introductions/innovations, research findings, and recent industry activity. The study analyzes market data and analytics in terms of value sales by the following application areas - Drug Discovery, Diagnostics and Others.
For more details about this comprehensive market research report, please visit -http://www.strategyr.com/Epigenetics_Market_Report.asp
About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a reputed publisher of off-the-shelf market research. Founded in 1987, the company is globally recognized as one of the world's largest market research publishers. The company employs over 800 people worldwide and publishes more than 1100 full-scale research reports each year. Additionally, the company also offers thousands of smaller research products including company reports, market trend reports, and industry reports encompassing all major industries worldwide.
Global Industry Analysts, Inc.
Web Site http://www.StrategyR.com/